The collaboration integrates IQVIA’s AI‑enabled clinical trial capabilities to enhance speed and efficiency, per the companies.

On Wednesday, TC BioPharm (Holdings) PLC (NASDAQ:TCBP) announced that its Board of Directors approved a special dividend of 0.25 American Depositary Shares for every 1 ADS held by shareholders, ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to ...

NYSE Composite attention surrounds IQVIA after expanded artificial intelligence clinical collaboration with Kexing Biopharm ...

(RTTNews) - TC BioPharm (TCBP), a clinical-stage biotechnology company, on Thursday announced the successful completion of dosing for Cohort A in the ACHIEVE Phase 2B UK clinical trial. The trial ...

TC BioPharm eliminated approximately 200 steps from its allogeneic CAR-T biomanufacturing process, reducing hands-on manufacturing time by half and cutting production costs to a fraction of the ...

BOSTON--(BUSINESS WIRE)--Infinata today announced the latest release of BioPharm Clinical, the leading tool to expedite study feasibility and clinical operations. This release features a completely ...

EDINBURGH, Scotland, March 23, 2022 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing ...

MIAMI--(BUSINESS WIRE)--Increased scrutiny and regulation in the nutraceutical and supplement market should be welcomed according to BioPharm CEO, Rafael Olartecoechea, producer of Vimulti® ...

US biotech Dance Biopharm is to work with Phillips-Medisize, to develop a version of its inhaled insulin device that has data connectivity for better management of diabetes treatment. Inhaled insulin ...

Shares of Sino Biopharmaceutical jumped after the Chinese pharma major said it plans to acquire Hangzhou Hygieia Biomedical. The stock rose as much as 5.5% on Wednesday morning in Hong Kong, and was ...